IL108522A0 - Pharmaceutical compositions containing adenosine deaminase inhibitors, for preventing or treating thrombosis ischemia and inflammatory conditions, especially sepsis - Google Patents

Pharmaceutical compositions containing adenosine deaminase inhibitors, for preventing or treating thrombosis ischemia and inflammatory conditions, especially sepsis

Info

Publication number
IL108522A0
IL108522A0 IL10852294A IL10852294A IL108522A0 IL 108522 A0 IL108522 A0 IL 108522A0 IL 10852294 A IL10852294 A IL 10852294A IL 10852294 A IL10852294 A IL 10852294A IL 108522 A0 IL108522 A0 IL 108522A0
Authority
IL
Israel
Prior art keywords
preventing
pharmaceutical compositions
compositions containing
inflammatory conditions
adenosine deaminase
Prior art date
Application number
IL10852294A
Original Assignee
Gensia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gensia Inc filed Critical Gensia Inc
Publication of IL108522A0 publication Critical patent/IL108522A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
IL10852294A 1993-02-03 1994-02-02 Pharmaceutical compositions containing adenosine deaminase inhibitors, for preventing or treating thrombosis ischemia and inflammatory conditions, especially sepsis IL108522A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1416093A 1993-02-03 1993-02-03

Publications (1)

Publication Number Publication Date
IL108522A0 true IL108522A0 (en) 1994-05-30

Family

ID=21763871

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10852294A IL108522A0 (en) 1993-02-03 1994-02-02 Pharmaceutical compositions containing adenosine deaminase inhibitors, for preventing or treating thrombosis ischemia and inflammatory conditions, especially sepsis

Country Status (3)

Country Link
AU (1) AU6297294A (en)
IL (1) IL108522A0 (en)
WO (1) WO1994017809A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL108524A0 (en) * 1993-02-03 1994-05-30 Gensia Inc Imidazodiazepine analogs
US5366960A (en) * 1993-08-26 1994-11-22 Warner-Lambert Company Method of treating cerebral and cardiovascular disorders employing [R]3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidaz 0-[4,5-d][1,3]diazepin-8-ol
CA2199615A1 (en) * 1996-02-12 1997-08-14 Elie Abushanab Erythro-hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemia traits
IL121272A (en) * 1997-07-10 2000-06-01 Can Fite Technologies Ltd Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
US6103702A (en) * 1999-05-24 2000-08-15 Board Of Trustees Of The University Of Illinois Use of adenosine deaminase inhibitors to treat systemic inflammatory response syndrome
AU6234000A (en) * 1999-07-22 2001-02-13 Supergen, Inc. Methods for treating autoimmune diseases
CN113995833B (en) * 2021-11-10 2023-12-26 南京南方元生物科技有限公司 Adenosine deaminase and application of modification thereof in preparation of diabetes wound repair drugs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673563A (en) * 1980-10-14 1987-06-16 The University Of Virginia Alumni Patents Foundation Adenosine in the treatment of supraventricular tachycardia
US4364922A (en) * 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
US5104859A (en) * 1985-09-24 1992-04-14 Solimedco Aktiebolag Continuous administration of adenosine to reduce pulmonary vascular resistance
US5231086A (en) * 1985-09-24 1993-07-27 Item Development Aktiebolag Continuous administration adenosine to increase myocardial blood flow
US4912092A (en) * 1986-03-27 1990-03-27 The Regents Of The University Of California Methods for increasing extracellular adenosine and for stabilizing mast cells

Also Published As

Publication number Publication date
AU6297294A (en) 1994-08-29
WO1994017809A1 (en) 1994-08-18

Similar Documents

Publication Publication Date Title
IL108523A0 (en) Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain
EP0693083A4 (en) Alpha-ketoamide derivatives as inhibitors of thrombosis
ZA936659B (en) Corrosion inhibitor compositions
ZA981132B (en) Methods, compositions and articles for reducing or preventing the effects of inflammation.
IL111785A0 (en) Dp-iv inhibitors and pharmaceutical compositions containing them
EP0568289A3 (en) Benzothiophenes and thienothiophenes and related compounds useful, for example, as urokinase inhibitors
IL125236A0 (en) Disinfecting compositions and processes for disinfecting surfaces
SG40042A1 (en) Process for producing alpha-olefin oligomers and alpha-olefin oligomer compositions
EP0406398A4 (en) Compositions and method for the treatment or prophylaxis of sepsis or septic shock
IL108075A0 (en) Enzyme inhibitors
PL319684A1 (en) Novel metaloprotease inhibitors, method of obtaining them and pharmaceutic compositions containing such inhibitors
HUP0000167A3 (en) Pyrroles as spla2 inhibitors, and pharmaceutical compositions containing them
AU7705694A (en) Substituted urea and isothiourea derivatives as no synthase inhibitors
HK1004488A1 (en) Stabilizer system for thiol-ene and thiol-nene compositions
SG52429A1 (en) Benzimidazole derivatives and composition for treating copper and copper alloy surfaces comprising the same
AU6183794A (en) Guanidinyl- or amidinyl-substituted methylamino heterocyclic thrombin inhibitors
IL125307A0 (en) Disinfecting compositions and processes for disinfecting surfaces
PL317709A1 (en) Steel corrosion inhibitors composition
ZA949148B (en) 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
ZA927874B (en) Corrosion inhibiting hydraulic additives and compositions containing same.
HUP9900071A3 (en) Tribenzimidazoles useful as topoisomerase i inhibitors, pharmaceutical compositions containing them and their use
GB9201165D0 (en) Corrosion inhibiting compositions
GB2270700B (en) Composition based on 1,1,1,3,3-pentafluorobutane and methylene chloride,for the cleaning and/or drying of solid surfaces
IL108522A0 (en) Pharmaceutical compositions containing adenosine deaminase inhibitors, for preventing or treating thrombosis ischemia and inflammatory conditions, especially sepsis
EP0599514A3 (en) Pyranoquinoline derivatives as inhibitors of cell proliferation.